Tg Therapeutics (TGTX) Goodwill & Intangibles (2011 - 2024)
Tg Therapeutics (TGTX) posted quarterly Goodwill & Intangibles of $799000.0 for Q1 2024, little changed year-over-year from $799000.0 in Q2 2023, and little changed quarter-over-quarter from $799000.0 in Q4 2023.
Analysis
Tg Therapeutics (TGTX) Goodwill & Intangibles (2011 - 2024) Analysis & Trends
Tg Therapeutics' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $799000.0 for Q1 2024.
- In Q1 2024, Goodwill & Intangibles changed 0.0% year-over-year to $799000.0; the TTM figure through Mar 2024 stood at $799000.0 (changed 0.0% YoY), while the FY2023 annual figure was $799000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles for Q1 2024 stood at $799000.0, roughly flat from $799000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $799000.0 in Q1 2020, with the low at $799000.0 in Q1 2020.
- The 5-year median for Goodwill & Intangibles is $799000.0 (2020), against an average of $799000.0.
- Peak annual rise in Goodwill & Intangibles reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
- Tg Therapeutics' Goodwill & Intangibles stood at $799000.0 in 2020, then changed by 0.0% to $799000.0 in 2021, then changed by 0.0% to $799000.0 in 2022, then changed by 0.0% to $799000.0 in 2023, then changed by 0.0% to $799000.0 in 2024.
- Business Quant data shows TGTX's Goodwill & Intangibles at $799000.0 in Q1 2024, $799000.0 in Q4 2023, and $799000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 799,000.00 |
| Dec 31, 2023 | 799,000.00 |
| Sep 30, 2023 | 799,000.00 |
| Jun 30, 2023 | 799,000.00 |
| Mar 31, 2023 | 799,000.00 |
| Dec 31, 2022 | 799,000.00 |
| Sep 30, 2022 | 799,000.00 |
| Jun 30, 2022 | 799,000.00 |
| Mar 31, 2022 | 799,000.00 |
| Dec 31, 2021 | 799,000.00 |
| Sep 30, 2021 | 799,000.00 |
| Jun 30, 2021 | 799,000.00 |
| Mar 31, 2021 | 799,000.00 |
| Dec 31, 2020 | 799,000.00 |
| Sep 30, 2020 | 799,000.00 |
| Jun 30, 2020 | 799,000.00 |
| Mar 31, 2020 | 799,000.00 |
| Dec 31, 2019 | 799,000.00 |
| Sep 30, 2019 | 799,000.00 |
| Jun 30, 2019 | 799,000.00 |